Cardiolipin and apoptosis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1585, Issue 2-3, 2002, Pages 97-107

  McMillin, Jeanie B ^a   Dowhan, William ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cardiolipin; Cardiomyopathy; Cytochrome c; Fatty acid; Ischemia; Membrane permeability pore; Mitochondrion; Phosphatidylglycerol

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CARDIOLIPIN; CYTOCHROME C; CYTOCHROME C OXIDASE; FATTY ACID; LONG CHAIN FATTY ACID; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE; PROTEIN BID;

ACYLATION; AGING; APOPTOSIS; CELL DEATH; CELL ENERGY; CELL FUNCTION; CELL STRUCTURE; DEACYLATION; DIET; ENERGY METABOLISM; ENZYME ACTIVITY; EUKARYOTE; HEART DILATATION; HEART MUSCLE CELL; HOMEOSTASIS; HUMAN; ISCHEMIA; LIPID DEGRADATION; LIPID METABOLISM; LIPID PEROXIDATION; LIPID TRANSPORT; LIPOGENESIS; LYSOSOME; MEMBRANE PERMEABILITY; METABOLIC DISORDER; MITOCHONDRION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TARGETING; REPERFUSION; REPERFUSION INJURY; REVIEW;

ACYLATION; ANIMALS; APOPTOSIS; CARDIOLIPINS; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CELLS, CULTURED; CYTOCHROME C GROUP; ELECTRON TRANSPORT COMPLEX IV; FATTY ACIDS; HUMANS; INTRACELLULAR MEMBRANES; MITOCHONDRIA, HEART; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MODELS, CHEMICAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EUKARYOTA;

EID: 0037203314     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00329-3     Document Type: Review

References (92)

1. Pangborn M.C. Isolation of a serologically positive phospholipid from beef heart. J. Biol. Chem. 143:1942;247-256.
2. Hatch G.M. Regulation of cardiolipin synthesis in the heart. Mol. Cell. Biochem. 159:1996;139-148.
3. Schlame M., Rua D., Greenberg M. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39:2000;257-288.
4. Minskoff S.A., Greenberg M.L. Phosphatidylglycerophosphate synthase from yeast. Biochim. Biophys. Acta. 1348:1997;187-191.
5. Xu F.Y., Taylor W.A., Hatch G.M. Lysiophosphatidylcholine inhibits cardiolipin biosynthesis in H9c2 cardiac myoblast cells. Arch. Biochem. Biophys. 349:1998;341-348.
6. Ragolia L., Tropp B.E. The effects of phosphoglycerides on Escherichia coli cardiolipin synthase. Biochim. Biophys. Acta. 1241:1994;323-332.
7. Jiang F., Gu Z., Granger J.M., Greenberg M.L. Cardiolipin synthase expression is essential for growth at elevated temperature and is regulated by factors affecting mitochondrial development. Mol. Microbiol. 31:1999;373-379.
8. Xu F.Y., Kelly S.L., Hatch G.M. N-Acetylsphingosine stimulates phosphatidylglycerolphosphate synthase activity in H9c2 cardiac cells. Biochem. J. 337:1999;483-490.
9. Matsko C.M., Hunter O.C., Rabinowich H., Lotze M.T., Amoscato A.A. Mitochondrial lipid alterations during Fas- and radiation-induced apoptosis. Biochem. Biophys. Res. Commun. 287:2001;1112-1120.
10. Schlame M., Brody S., Hostetler K.Y. Mitochondrial cardiolipin in diverse eukaryotes. Comparison of biosynthetic reactions and molecular acyl species. Eur. J. Biochem. 212:1993;727-735.
11. Schlame M., Rustow B. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem. J. 272:1990;589-595.
12. Ma B.J., Taylor W.A., Dolinsky V.W., Hatch G.M. Acylation of monolysocardiolipin in rat heart. J. Lipid Res. 40:1999;1837-1845.
13. Nakahara I., Kikuchi H., Taki W., Nishi S., Kito M., Yonekawa Y., Goto Y., Ogata N. Changes in major phospholipids of mitochondria during postischemic reperfusion in rat brain. J. Neurochem. 76:1992;244-250.
14. Ostrander D.B., Sparagna G.C., Amoscato A.A., McMillin J.B., Dowhan W. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced apoptosis. J. Biol. Chem. 276:2001;38061-38067.
15. Weglicki W.B., Low M.G. Phospholipases of the myocardium. Basic Res. Cardiol. 82:1987;102-112.
16. 2+ release in isolated liver mitochondria. Biochim. Biophys. Acta. 1304:1996;129-138.
17. Tuominen E.K.J., Wallace C.J.A., Kinnunen P.K.J. Phospholipid-cytochrome c interaction. Evidence for the extended lipid anchorage. J. Biol. Chem. 277:2002;8822-8826.
18. Jemmerson R., Liu J., Hausauer D., Lam K.-P., Mondino A., Nelson R.D. A conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the natice antigen with synthetic phospholipid vesicles. Biochemistry. 38:1999;3599-3609.
19. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. U. S. A. 99:2002;1259-1263.
20. Blomstrand R., Svensson L. Observations on lipid composition with particular reference to cardiolipin in rat heart after feeding rapeseed oil. Acta Med. Scand., Suppl. 585:1975;51-73.
21. Borg K. Physiopathological effects of rapeseed oil: a review. Acta Med. Scand., Suppl. 58:1975;5-13.
22. Hung S., Umemura T., Yamashiro S., Slinger S.J. The effects of original and randomized rapeseed oils containing high or very low levels of erucic acid on cardiac lipids and myocardial lesions in rats. Lipids. 12:1977;215-221.
23. Kagiyama K., Pauly D.F., Hughes H., Yoon B.Y., Entman M.L., McMillin-Wood J.B. Protection by verapamil of mitochondria glutathione equilibrium and phospholipid changes during reperfusion of ischemic canine myocardium. Circ. Res. 61:1987;301-310.
24. Lenefsky E.J., Slabe T.J., Stoll M.S., Minkler P.E., Hoppel C.L. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am. J. Physiol. 280:2001;H2770-H2778.
25. McMillin J.B., Taffet G.E., Taegtmeyer H., Hudson E.K., Tate C.A. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc. Res. 27:1993;2222-2228.
26. 2+ activation of PDH. Am. J. Physiol. 276:1999;H149-H158.
27. Paradies G., Ruggiero F.M., Petrosillo G., Quagliariello E. Age-dependent decline in the cytochrome oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett. 406:1997;136-138.
28. Paradies G., Petrosillo G., Pistolese M., Di Venosa N., Serena D., Ruggiero F.M. Lipid peroxidation and alterations to oxidative metabolism in mitochondria from rat heart subjected to ischemia and reperfusion. Free Radic. Biol. Med. 27:1999;42-50.
29. Hansford R.G., Tsuchiya N., Pepe S. Mitochondria in heart ischemia and aging. Biochem. Soc. Symp. 66:1999;141-147.
30. McMillin J.B., Bick R.J., Benedict C.R. Influence of dietary fish oil on mitochondrial function and response to ischemia. Am. J. Physiol. 263:1992;H1479-H1485.
31. Vasdev S.C., Biro G.P., Narbaitz R., Kako K.J. Membrane changes induced by early myocardial ischemia in the dog. Can. J. Biochem. 58:1980;1112-1119.
32. Pepe S. Mitochondrial function is ischaemia and reperfusion of the ageing heart. Clin. Exp. Pharmacol. Physiol. 27:2000;745-750.
33. Ardail D., Lerme F., Louisot P. Phospholipid import into mitochondria: possible regulation mediated through lipid polymorphism. Biochim. Biophys. Acta. 186:1992;1384-1390.
34. Hostetler K.Y. Polyglycerophospholipids: phosphatidylglycerol, diphosphatidylglycerol and bis (monoacylglycerol) phosphate. Hawthorne J.N., Ansell G.B. Phospholipids. 1982;215-261 Elsevier, Amsterdam.
35. deWinter J.M., Lenting H.B., Neys F.W., vanden Bosch H. Hydrolysis of membrane-associated phosphoglycerides by mitochondrial phospholipase A2. Biochim. Biophys. Acta. 917:1987;169-177.
36. Hambrey P.N., Mellors A. Cardiolipin degradation by rat liver lysosomes. Biochem. Biophys. Res. Commun. 62:1975;939-945.
37. Esposti M.D., Erler J.T., Hickman J.A., Dive C. Bid, a widely expressed pro-apoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol. Cell. Biol. 21:2001;7268-7276.
38. Petrosillo G., Ruggiero F.M., Pistolese M., Paradies G. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in apoptosis. FEBS Lett. 509:2001;435-438.
39. Chien K.R., Han A., Sen A., Buja L.M., Willerson J.T. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids. Circ. Res. 54:1984;313-322.
40. Fonteh A.N., LaPorte T., Swan D., McAlexander M.A. A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis. J. Biol. Chem. 276:2001;1439-1449.
41. Robinson N.C. Functional binding of cardiolipin to cytochrome oxidase. J. Bioenerg. Biomembranes. 25:1993;153-163.
42. Hasinoff B.B., Davey J.P., O'Brien P.J. The adriamycin (doxorubicin)-induced inactivation of cytochrome c oxidase depends on the presence of iron or copper. Xenobiotica. 19:1989;231-241.
43. Nicolay K., de Kruijff B. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Biochim. Biophys. Acta. 892:1987;320-330.
44. Giuffre A., Sarti P., D'Itri E., Buse G., Soulimane T., Brunori M. On the mechanism of inhibition of cytochrome c oxidase by nitric oxide. J. Biol. Chem. 271:1996;33404-33408.
45. Shiva S., Brookes P.S., Patel R.P., Anderson P.G., Darley-Usmar V.M. Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7212-7217.
46. Hofman B., Stockl A., Schlame M., Beyer K., Klingenberg M. The reconstituted ADP/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants. J. Biol. Chem. 269:1994;1940-1944.
47. Halestrap A.P. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem. Soc. Symp. 66:1999;181-203.
48. Crompton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr. Opin. Cell Biol. 12:2000;414-419.
49. Crompton M. Mitochondrial junctional complexes and their role in cell death. J. Physiol. 529:2000;11-21.
50. Dolder M., Wendt S., Walliman T.-F. Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol. Signals Recept. 10:2001;93-111.
51. Lutter M., Fang M., Luo X., Nishijima M., Wang X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat. Cell Biol. 2:2000;754-761.
52. Noel H., Pande S.V. An essential requirement of cardiolipin for mitochondrial carnitine acylcarnitine translocase activity. Lipid requirement of carnitine acylcarnitine translocase. Eur. J. Biochem. 155:1986;99-102.
53. Bisaccia F., De Palma A., Preziosa G., Palmieri F. Kinetic characterization of the reconstituted tricarboxylic acid carrier from rat liver mitochondria. Biochim. Biophys. Acta. 1019:1990;250-256.
54. Nalecz K.A., Bolli R., Wojtczak L., Azzi A. The monocarboxylate carrier from bovine heart mitochondria: partial purification and its substrate-transporting properties in a reconstituted system. Biochim. Biophys. Acta. 851:1986;29-37.
55. Bisaccia F., Palmieri F. Specific elution from hydroxyapatite of the mitochondrial phosphate carrier by cardiolipin. Biochim. Biophys. Acta. 766:1984;386-394.
56. Chang S.C., Heacock P.N., Mileykovskaya E., Voelker D.R., Dowhan W. Isolation and characterization of the gene (CLS1) encoding cardiolipin synthase in Saccharomyces cerevisiae. J. Biol. Chem. 273:1998;14933-14941.
57. Jiang F., Rizavi H.S., Greenberg M.L. Cardiolipin is not essential for the growth of Saccharomyces cerevisiae on fermentable or non-fermentable carbon sources. Mol. Microbiol. 26:1997;481-491.
58. Jiang F., Ryan M.T., Schlame M., Zhao M., Gu Z., Klingenberg M., Pfanner N., Greenberg M.L. Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J. Biol. Chem. 275:2000;22387-22394.
59. Koshkin V., Greenberg M.L. Oxidative phosphorylation in cardiolipin-lacking yeast mitochondria. Biochem. J. 347:2000;687-691.
60. Chang S.C., Heacock P.N., Clancey C.J., Dowhan W. The PEL1 gene (renamed PGS1) encodes the phosphatidylglycerophosphate synthase of Saccharomyces cerevisiae. J. Biol. Chem. 273:1998;9829-9836.
61. Ostrander D.B., Zhang M., Mileykovskaya E., Rho M., Dowhan W. Lack of mitochondrial anionic phospholipids causes an inhibition of translation of protein components of the electron transport chain. A yeast genetic model system for the study of anionic phospholipid function in mitochondria. J. Biol. Chem. 276:2001;25262-25272.
62. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341:1999;233-249.
63. Vreken P., Valianpour F., Nijtmans L.G., Grivell L.A., Plecko B., Wanders R.J.A., Barth P.G. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth Syndrome. Biochem. Biophys. Res. Commun. 279:2000;378-382.
64. Neuwald A.F. Barth syndrome may be due to an acyl transferase deficiency. Curr. Biol. 7:1997;R465-R466.
65. Kawasaki K., Kuge O., Chang S.C., Heacock P.N., Rho M., Susuli K., Nishijama M., Dowhan W. Isolation of a Chinese hamster ovary (CHO) cDNA encoding phosphatidylyglycerolphosphate (PGP) synthase, expression of which corrects the mitochondrial abnormalities of a PGP synthase defective mutant of CHO-K1 cells. J. Biol. Chem. 274:1999;1828-1834.
66. Cesslli D., Jakoniuk I., Barluchi L., Beltrami A.P., Hintze T.H., Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ. Res. 89:2001;198-200.
67. Bleyl S.B., Mumford B.R., Thompson V., Carey J.C., Pysher T.J., Chin T.K., Ward K. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am. J. Hum. Genet. 61:1997;868-872.
68. Corrado G., Santarone M., Miglierina E., Beretta S., Frattini T., Tadeo G., Manzillo G.F., Tagliagambe L.M. Isolated noncompaction of the ventricular myocardium. A study in an adult male and literature review. Ital. Heart J. 1:2000;372-375.
69. Brandt J., Djouadi F., Kelly D.P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α J. Biol. Chem. 273:1998;8560-8563.
70. Mascaro C., Acosta E., Ortiz J.A., Marrero P.F., Hegardt F.G., Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273:1998;8560-8563.
71. Van der Lee K.A., Vork M.M., De Vries J.E., Willemsen P.H., Glatz J.F., Reneman R.S., Van der Vusse G.J., Van Bilsen M. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J. Lipid Res. 41:2000;41-47.
72. Vega R.B., Huss J.M., Kelly D.P. The co-activator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding fatty acid oxidation enzymes. Mol. Cell. Biol. 20:2000;1868-1876.
73. DeMaugre F., Bonnefont J.-P., Colonna M., Cepanec C., Leroux J.-P., Saudubray J.-M. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. J. Clin. Invest. 87:1991;859-864.
74. Rhead W.J. Inborn errors of fatty acid oxidation in man. Clin. Biochem. 24:1991;319-329.
75. Katz A.M., Messineo F.C. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ. Res. 48:1981;1-16.
76. Ramasamy R., Hwang Y., Bakr S., Bergmann S.R. Protection of ischemic hearts perfused with an anion exchange inhibitor, DIDS, is associated with beneficial changes in substrate metabolism. Cardiovasc. Res. 51:2001;275-282.
77. Kleinfeld A.M., Prothro D., Brown D.L., Davis R.C., Richieri G.V., DeMaria A. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am. J. Cardiol. 78:1996;1350-1354.
78. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
79. Lopaschuk G.D., Spafford M.A., Davies N.J., Wall S.R. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ. Res. 66:1990;546-553.
80. Turcani M., Rupp H. Etomoxir improves left ventricular performance of pressure-overloaded rat heart. Circulation. 96:1997;3681-3686.
81. De Vries J.E., Vork M.M., Roemen T.H.M., de Jong Y.F., Cleutjens J.P.M., van der Vusse G.J., van Bilsen M. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J. Lipid Res. 38:1997;1384-1394.
82. Hickson-Bick D.L., Buja L.M., McMillin J.B. Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J. Mol. Cell. Cardiol. 32:2000;511-519.
83. Sparagna G.C., Hickson-Bick D.L., Buja L.M., McMillin J.B. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am. J. Physiol. 279:2000;H2124-H2132.
84. Paumen M.B., Ishida Y., Muramatsu M., Yamamoto M., Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J. Biol. Chem. 272:1997;3324-3329.
85. Gudz T.I., Tserng K.-Y., Hoppel C.L. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J. Biol. Chem. 272:1997;24154-24158.
86. Bielawska A.E., Shapiro J.P., Jiang L., Melkonyan H.S., Piot C., Wolfe C.L., Tomei L.D., Hannun Y.A., Umansky S.R. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J. Pathol. 151:1997;1257-1263.
87. Listenberger L.L., Ory D.S., Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 276:2001;14890-14895.
88. Woldegiorgis G., Yousufzai S.Y., Shrago E. Studies on the interaction of palmitoyl-CoA with the adenine nucleotide translocase. J. Biol. Chem. 257:1982;14783-14787.
89. Wieckowski M.R., Brdiczka D., Wojtczak L. Long-chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore. FEBS Lett. 484:2000;61-64.
90. Ushmorov A., Ratter F., Lehman V., Dröge W., Schirrmacher V., Umansky V. Nitric oxide-induced apoptosis in human leukemia lines requires mitochondrial lipid degradation and cytochrome c release. Blood. 93:1999;2342-2352.
91. Hickson-Bick D.L., Sparagna G.C., Buja L.M., McMillin J.B. Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of reactive oxygen species. Am. J. Physiol., Heart Circ. Physiol. 282:2001;H656-H664.
92. Sparagna G.C., Hickson-Bick D.L., Buja L.M., McMillin J.B. Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling. Antioxid. Redox Signal. 3:2001;71-79.